Profile
PRVB NVO REGN VRTX MRNA SGEN
Company Name Provention Bio, Inc. Novo Nordisk A/S Regeneron Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $2.38B $566.57B $103.71B $103.60B $47.86B $43.15B
Employees 0.17K 66.02K 13.68K 5.40K 5.60K 3.26K
CEO Mr. Ashleigh W. Palmer B.Sc., M.B.A. Mr. Lars Fruergaard Jorgensen Dr. Leonard S. Schleifer M.D., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
Trading
PRVB NVO REGN VRTX MRNA SGEN
Last Close $24.98 $123.05 $957 $401.08 $125 $228.74
High 52 $24.98 $199.54 $993.35 $446.08 $137.75 $228.9
Low 52 $24.98 $87.78 $692.45 $323.57 $69.51 $187.64
Price vs. 52 Week High 0 % -38.33 % -3.66 % -10.09 % -9.26 % -0.07 %
Price vs. 52 Week Low 0 % 40.18 % 38.2 % 23.95 % 79.83 % 21.9 %
Total Return
PRVB NVO REGN VRTX MRNA SGEN
1 Month Return 0 % -2.23 % 1.52 % -1.37 % 21.5 % 0 %
3 Month Return 0 % 4.05 % 2.21 % -6.48 % 30.9 % 0 %
6 Month Return 0 % 25.34 % 17.15 % 6.61 % 61.23 % 6.39 %
9 Month Return 0 % -21.42 % 24.86 % 17.8 % 15.54 % 18.23 %
YTD Return 0 % 18.95 % 8.96 % -1.43 % 25.69 % 0 %
1 Year Return 0 % -24.62 % 25.57 % 15.22 % -8.79 % 14.44 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PRVB NVO REGN VRTX MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -56.14 % 1.1 % 6.2 % 13.69 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
PRVB NVO REGN VRTX MRNA SGEN
Asset Growth 74.65 % 30.35 % 13.23 % 25.23 % -28.74 % -1.21 %
Gross Profit Growth 787.67 % 32.32 % 6.49 % 9.25 % -85.12 % 22.93 %
Revenue Growth 824.37 % 31.26 % 7.76 % 10.17 % -64.94 % 24.65 %
Revenue 3 Year - 90.51 % 55.67 % 59.87 % 2356.27 % 91.84 %
Revenue 5 Year - 124.2 % 110.3 % 218.58 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 549.62 % 608.27 % 6447.35 % 494.04 %
EBIT Growth -10.89 % 37.11 % -14.6 % -12.94 % -145 % 10.13 %
Net Income Growth 0.76 % 50.71 % -8.87 % 8.96 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -46.76 % 106.79 % 13.48 % 34.59 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share -463.81 % 133.86 % 74.02 % 70.33 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share - 98.61 % 871.12 % 809.6 % -2046.03 % -624.16 %
Operating Income Growth -10.89 % 37.11 % -14.6 % -12.94 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) 20.94 % 38.06 % -8.39 % -14.35 % -162.6 % 9.07 %
Operating 3 Year CFG -14.02 % 118.29 % 76.95 % 9.63 % -253.56 % -148.34 %
Operating 5 Year CFG -600.42 % 163.51 % 125.17 % 174.78 % -100.11 % -195.86 %
Operating 10 Year CFG - 150.92 % 713.56 % 5187.08 % -4698.89 % -2622.09 %
EPS Growth 16.02 % 52.28 % -8.54 % 8.33 % -158.15 % 10.81 %
EPS Diluted Growth 16.02 % 52.37 % -9.03 % 8.35 % -161.39 % 10.81 %
Book Value Per Share 135.23 % 29 % 15.03 % 25.58 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 184.04 % 75.22 % 137.56 % 104.06 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share 174.18 % 121.9 % 219.1 % 291.14 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share - 49.62 % 1286.9 % 1030.79 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 3952.54 % 4.74 % 0.06 % 44.1 % 3.58 % -23.28 %
Free Cash Flow Growth 20.91 % 9.17 % -17.11 % -16.47 % -183.5 % 3.67 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
PRVB NVO REGN VRTX MRNA SGEN
Gross Profit Margin TTM 95.57 % 84.65 % 87.16 % 87.21 % 21.77 % 75.4 %
Return on Assets TTM -25.95 % 29.87 % 11.22 % 15.92 % -35.67 % -20.64 %
Return on Equity TTM -46.11 % 91.82 % 15.15 % 22.62 % -41.83 % -28.06 %
Return on Capital Employed TTM -47.28 % 82.5 % 12.53 % 19.82 % -35.81 % -29.5 %
Net Income Per EBT TTM 90.06 % 79.81 % 95.44 % 82.64 % 124.28 % 101.53 %
EBT Per Ebit TTM 98.55 % 101.7 % 104.74 % 115.19 % 93.44 % 93.47 %
EBIT Per Revenue TTM -598.56 % 45.03 % 29.46 % 38.53 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -133.59 % 346.88 % 238.94 % 437.57 % -232.98 % -475.96 %
Receivables Turnover TTM 8.51 3.87 2.51 6.31 13.32 3.64
Payables Turnover TTM 0.08 2.88 2.51 3.46 22.04 2.52
Inventory Turnover TTM 0.42 1.12 0.62 1.71 13.67 1.07
Fixed Asset Turnover TTM 458 % 248.64 % 310.02 % 679.28 % 186.78 % 471.71 %
Asset Turnover TTM 4.88 % 81.71 % 38.12 % 43.42 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -0.43 20.95 43.96 13.73 -7.54 -2.87
Free Cash Flow Per Share TTM -0.44 11.28 36.87 12.72 -9.61 -3.73
Cash Per Share TTM 220.82 % 208.61 % 9758.35 % 4354.48 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -276.1 % 38.24 % 36.17 % 35.84 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.78 % 53.85 % 83.87 % 92.69 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -133.59 % 346.88 % 238.94 % 437.57 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -73.06 78.04 26.09 31.6 -13.03 -61.54
Price To Operating Cash Flows Ratio TTM -58.44 40.71 21.77 29.22 -16.57 -79.67
Price Cash Flow Ratio TTM -58.44 40.71 21.77 29.22 -16.57 -79.67
Income Statement (TTM)
PRVB NVO REGN VRTX MRNA SGEN
Revenue $0.01B $232.26B $13.12B $9.84B $6.75B $1.96B
Gross Profit $0.01B $196.5B $11.3B $8.58B $2.06B $1.55B
Gross Profit Ratio 96.03% 84.6% 86.16% 87.17% 30.52% 79.1%
EBITDA $-0.12B $112.94B $5.13B $3.93B $-3.21B $-0.62B
Net Income $-0.11B $83.68B $3.95B $3.62B $-4.71B $-0.61B
EPS Diluted -1.52 18.62 34.77 13.89 -12.34 -3.3
Balance Sheet (MRQ)
PRVB NVO REGN VRTX MRNA SGEN
Long Term Debt $0.02B $20.53B $2.7B $0.72B $1.22B $0.04B
Total Liabilities $0.12B $207.93B $7.11B $5.15B $4.57B $0.87B
Total Equity $0.12B $106.56B $25.97B $17.58B $13.85B $2.8B
Total Investments $0.12B $17.5B $13.51B $3.45B $4.68B $1.42B
Total Debt $0.02B $27.01B $2.7B $0.81B $1.24B $0.04B
Total Assets $0.24B $314.49B $33.08B $22.73B $18.43B $3.67B
Cash Flow Statement (TTM)
PRVB NVO REGN VRTX MRNA SGEN
Net Income $-0.11B $83.68B $3.95B $3.62B $-4.71B $-0.61B
Inventory $-0B $-7.42B $-0.27B $-0.32B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.08B $108.91B $4.59B $3.54B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.93B $-0.26B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.12
ABCL AbCellera Biologics Inc. 4.03
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.615
ABIO ARCA biopharma, Inc. 3.26
ABOS Acumen Pharmaceuticals, Inc. 3.49
ABSI Absci Corporation 5.08
ABUS Arbutus Biopharma Corporation 2.71
ABVC ABVC BioPharma, Inc. 1.08
ABVX Abivax SA American Depositary Shares 14.54
ACAD ACADIA Pharmaceuticals Inc. 17.05
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.45
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.8037
ACHV Achieve Life Sciences, Inc. 4.735
ACIU AC Immune SA 2.39
ACLX Arcellx, Inc. 52.69
ACRV Acrivon Therapeutics, Inc. Common Stock 9.59
ACST Acasti Pharma Inc. 2.96
ETFs With Exposure to PRVB
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.02 201.9
IBB iShares Biotechnology ETF 0.06 132.96
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 112.47
NUV Nuveen Municipal Value Fund, Inc. 0.14 8.56
IWN iShares Russell 2000 Value ETF 0.01 154.21
IWV iShares Russell 3000 ETF 0 292.33
NVG Nuveen AMT-Free Municipal Credit Income Fund 0.14 11.82
IWO iShares Russell 2000 Growth ETF 0.04 256.87
BIB ProShares Ultra Nasdaq Biotechnology 0.06 55.7
HDG ProShares Hedge Replication ETF 0.01 49.26
UWM ProShares Ultra Russell2000 0.03 37.23
XPH SPDR S&P Pharmaceuticals ETF 3.3 40.78
ONEQ Fidelity Nasdaq Composite Index ETF 0.03 63.66
IWC iShares Micro-Cap ETF 0.13 116.72
DWAS Invesco DWA SmallCap Momentum ETF 1 87.06
FHLC Fidelity MSCI Health Care Index ETF 0.03 66.52
URTY ProShares UltraPro Russell2000 0.02 43.67
VTWV Vanguard Russell 2000 Value Index Fund 0.02 135.77
PILL Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 0.67 6.83
BTEC Principal Healthcare Innovators ETF 0.58 36.9
MRGR ProShares Merger ETF 2.31 40.0618
NUSC Nuveen ESG Small-Cap ETF 0.14 39.49
NUW Nuveen AMT-Free Municipal Value Fund 0.14 13.63
PBSM Invesco PureBeta MSCI USA Small Cap ETF 0.05 31.9152
PTH Invesco DWA Healthcare Momentum ETF 4.18 42.05
VFMO Vanguard U.S. Momentum Factor ETF 0.09 146.27
VTWG Vanguard Russell 2000 Growth Index Fund 0.1 186.82
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.42 30.95
VQNPX Vanguard Growth and Income Fund 0 60.65
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 99.01
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.01 58.79
ESML iShares ESG Aware MSCI USA Small-Cap ETF 0.1 38.5
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0.02 34.1348
RYLD Global X Russell 2000 Covered Call ETF 0.05 16.48
AVUS Avantis U.S. Equity ETF 0 86.93
IBBQ Invesco Nasdaq Biotechnology ETF 0.19 21.9
DFAS Dimensional U.S. Small Cap ETF 0 60.09
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.19357 5.87
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.05 6.3225
WSML.L iShares MSCI World Small Cap UCITS ETF 0.02 7.0785
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.0635 6.58
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.17389 454.5
DRDR.L iShares Healthcare Innovation UCITS ETF 0.07 593
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.02 5.644
2B78.DE iShares Healthcare Innovation UCITS ETF 0.25432 6.915
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.14586 4.482
Unlock